Could changing gut bacteria boost cancer treatment?
NCT ID NCT06728072
Summary
This study is testing whether adding a combination of two common antibiotics (ciprofloxacin and metronidazole) and aspirin to standard chemotherapy helps people with advanced colorectal cancer. Researchers want to see if changing the bacteria in the gut (the microbiome) can make the cancer respond better to treatment. The trial will measure tumor shrinkage, survival time, and side effects in about 97 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23298, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.